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PURPOSE: We sought to determine whether an early CT ischemic lesion showing parenchymal
hypoattenuation might be undetectable on diffusion-weighted imaging (DWI) in acute cerebral
ischemia.
MATERIALS AND METHODS: We retrospectively evaluated CT and MR images of 70 consecutive
patients with acute middle cerebral artery (MCA) infarction. All patients underwent CT and MR imaging
within 6 hours of symptom onset. We determined the presence of reversed discrepancy (RD), defined
as an early ischemic lesion showing parenchymal hypoattenuation on CT but no hyperintensity on DWI.
CT Hounsfield units (HU), apparent diffusion coefficients (ADCs), and perfusion parameters were
calculated for RD lesions.
RESULTS: RD was found in 9 (12.9%) patients and at basal ganglia (89%). The mean HU of RD lesion
was lower than that of normal tissue (HU, 2.33  0.74, P  .001). RD lesions showed no significant
decrease of ADC (ADC ratio, 0.97 0.07, P .059) and cerebral blood flow (relative CBF, 0.87 0.20,
P  0.05). Delayed DWI hyperintensity occurred in 8 (88.8%) RD lesions, and all lesions progressed to
infarction. In 6 (66%) of 9 patients with RD, Alberto Stroke Program Early CT scores of ischemic lesions
were lower on CT than those on DWI.
CONCLUSION: RD was uncommonly found mainly in basal ganglia, and all RD lesions progressed to
infarction at follow-up. Early CT ischemic lesion showing parenchymal hypoattenuation may be
undetectable on DWI, and DWI may underestimate extent of severe ischemic tissue in patients with
acute MCA infarction.
In patients with acute ischemic stroke, early ischemicchanges on CT include parenchymal hypoattenuation, loss
of gray-white matter distinction, and brain swelling with sul-
cal effacement.1-4 Although the significance of early ischemic
changes remains controversial within 3 hours after symptom
onset,4,5 patients showing large parenchymal hypoattenuation
have a high risk of symptomatic hemorrhage after tissue plas-
minogen activator (tPA) treatment.3 An early CT ischemic
lesion showing hypoattenuation indicates severe ischemic
edema, critical hypoperfusion, and irreversible ischemic
injury.6,7
RecentMR imaging studies8-11 have suggested thatMR im-
aging has the potential to be the first imagingmethod formak-
ing a decision of thrombolytic therapy in acute ischemic
stroke. Diffusion-weighted imaging (DWI)–hyperintense le-
sions, though rarely permanently reversible, usually represent
ischemic tissue that will progress to infarction.12-14 In most
cases of acute cerebral ischemia, the size of a hyperintense
lesion onDWI is similar to or larger than that onCT, and there
is a correlation of lesion size between CT and DWI.15,16 How-
ever, little documentation is available on a finding of reversed
discrepancy (RD) between CT and DWI in acute cerebral
ischemia.16,17
This study was performed to determine whether an early
CT ischemic change of parenchymal hypoattenuation may be
undetectable on DWI, and to determine whether the extent of
severe ischemic tissue may be underestimated on DWI in pa-
tients with untreated acute middle cerebral artery (MCA)
infarction.
Materials and Methods
Patients
BetweenMay 1997 and June 2004, 215 consecutive patients who pre-
sented with acute MCA infarct and a National Institutes of Health
Stroke Scale (NIHSS) score of more than 3 underwent CT within 6
hours of symptom onset. MR imaging was performed after CT on the
same day in 210 patients. Of these 210, we retrospectively included 70
patients (40men and 30 women; mean age, 70 years) who underwent
MR imaging within 6 hours of symptom onset and who did not un-
dergo thrombolytic therapy.
CT and MR Imaging
All CT scans were obtained using a helical CT scanner or multidector
CT (Hi-Speed Advantage or LightSpeed Ultra; GE Medical Systems,
Milwaukee, Wis). The scanning parameters of the unenhanced CT
were 120 kV and 240 or 300 mAs with a 512 512 image matrix, 23-
or 24-cm field of view, and a 5-mm section thickness. Maximal inten-
sity projection CT angiography (CTA) was obtained from enhanced
CT source data obtained according to a protocol of multiphasic per-
fusion CT.16
MR imaging was performed using a 1.5T unit (GE Medical Sys-
tems) with echo-planar imaging (EPI) sequences, including diffu-
sion- and perfusion-weighted imaging (DWI/PWI). The typical
stroke MR imaging protocol consisted of DWI, PWI, T2* gradient-
echo, gadolinium-enhanced T1-weighted imaging, and 3D time-of-
flight MR angiography (MRA). Imaging parameters of DWI were as
follows: repetition time (TR), 6500–10,000ms; echo time (TE), 71.7–
96.8ms; matrix, 128 128; 3 directions; field of view (FOV), 24 or 28
cm; section thickness, 5 mm; and intersection gap, 2 mm. DWI was
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obtainedwith b values of 0 and 1000 s/mm2. PWIwas performedwith
gradient-echo, echo-planar sequenceswith following parameters: TR,
2000 ms; TE, 60 ms; flip angle, 90°; matrix, 128 128, FOV, 24 cm;
section thickness, 5 mm; and intersection gap, 2 mm. A series of
images (8–10 sections, 40–50 images per section) was obtained be-
fore, during, and after administration of the contrast agent. Perfusion
maps of relative cerebral blood volume (rCBV), time-to-peak (TTP),
and relative cerebral blood flow (rCBF)were generated after eliminat-
ing the recirculation of contrast agent by -variate curve fitting. The
rCBFmap was obtained via the singular value decomposition decon-
volution method.18,19
Determination of Reversed Discrepancy, Extent of
Ischemic Lesion and Arterial Occlusion
In a retrospective manner, 2 neuroradiologists (D.G.N. and E.Y.K.)
independently reviewedCT andDWI and determined the presence of
RD. Disagreements were decided by consensus. The interpreters were
unaware of initial MRAs, follow-up images, and clinical information
except for information of affected hemisphere. The lesion exhibiting
RD was defined as an early ischemic lesion that showed parenchymal
hypoattenuation or loss of gray and white matter distinction on CT
but no obvious hyperintensity onDWI. RDwas determinedwhen the
extent of the RD was equivalent to an Alberta Stroke Program Early
CT Score (ASPECTS)20 of at least 1 in the affected MCA territory. In
all patients with RD, the extent of ischemic lesion was assessed using
ASPECTS by parenchymal hypoattenuation on CT and by parenchy-
mal hyperintensity on DWI. For determining ASPECTS, CT or DWI
was reviewed independently of each image at a separate session. The 2
interpreters evaluated initial CTAs, initial MRAs, and follow-up (day
1)MRAs by consensus to determine arterial occlusion andpresence of
arterial recanalization, and recanalization rate of arterial occlusions at
day 1 was compared between the patients with and without RD.
Quantitative Measurement of Reversed Discrepancy
Lesions
In all patients with RD, initial and follow-up MR imaging, including
DWI, PWI, andMRA,were successfully obtained 1 day after the initial
MR imaging except for 1 patient (patient 4) in whom the initial PWI
was not optimally obtained because of poor contrast enhancement.
The PWI data from the patient 4 was not used in the analysis.
CT Hounsfield units (HU), ADC, DWI signal intensity, T2 signal
intensity, TTP, rCBV, and rCBF values were measured by the final
3 regions of interest (ROIs) of RD lesion (only CT positive), DWI
lesion 1 (both CT and DWI positive), and DWI lesion 2 (only DWI
positive). All DWI and PWI images were spatially coregistered to the
first volume of CT scans or EPI T2-weighted images (DWI b 0) to
superimpose the ROIs delineated on CT images using SPM2 (Well-
come Department of Cognitive Neuroscience). The 2 neuroradiolig-
sts manually drew ROIs by consensus along the margins of the hy-
poattenuated lesions on CT and then drew ROIs along themargins of
the hyperintense lesions on DWI in all patients with RD (Fig 1). Each
ROImade on CT was superimposed on the same DWI images, which
allowed us to make an ROI only for a lesion with RD (ROIRD) and
ROIs for the whole DWI lesions (ROIDW), DWI lesion 1 (ROIDW1),
and DWI lesion 2 (ROIDW2). The final 3 ROIs of RD lesion (ROIRD),
DWI lesion 1(ROIDW1), andDWI lesion 2 (ROIDW2)were transferred
to the corresponding coregistered images of the initial CT, DWI, and
PWI maps including TTP, rCBV, and rCBF. For comparison, mirror
ROIs were drawn on the contralateral hemisphere. The size of ROI
ranged from 1.2 to 30.4 cm2. The ADC values were thresholded at
1200 106 mm2/s to minimize partial volume effect with CSF. The
same quantitative measurements using ROIs were performed for fol-
low-up MR imaging obtained at day 1 in patients with RD.
Clinical Data Analysis
A stroke neurologist assessed baseline, acute (days 1 and 7), and
chronic (day 90) clinical data using the modified Rankin Score
(mRS), and then compared for patients with and without RD. The
incidence of spontaneous rapid clinical improvement (NIHSS score
more than 3) within a few hours after stroke was assessed and com-
pared for 2 subgrouppatients. Time duration fromonset toCTorMR
imaging and the time interval between CT and MR imaging were
compared between the 2 groups. The incidence of RD was compared
between the patients who underwent MR imaging within 3 hours
after symptom onset and those who underwent imaging at 3 to 6
hours. Hemorrhagic transformation was determined on T2* gradi-
ent-echo images at day 1.
Statistical Analysis
Statistical analysis was performed using commercial software (SPSS-
PC, version 10.0; SPSS, Chicago, Ill). Comparisons ofmean values for
CT attenuation, ADC, DWI signal intensity, TTP, CBV, and CBF
between lesions and contralateral hemispheres, and mean values for
CT attenuation, ADC, ADC ratio, DWI signal intensity ratio, TTP
delay, rCBV, and rCBF between lesions with RD and DWI lesions
were compared with the use of a paired t test. When variables were
non-normally distributed, comparisons were performed with the use
of the Wilcoxon signed-rank test. Comparisons of clinical scores be-
tween the 2 subgroup patients with and without RD were performed
with the use of the Student t test. The 2 test or Fisher exact test was
used to compare recanalization rates of arterial occlusions at day 1
and the incidence of rapid clinical improvement between patients
with and without RD. A P value of 0.05 was considered statistically
significant. Two observers independently determinedASPECT scores
on both CT and DWI. Each observer determined the presence of RD
when the case showed discrepancy in the areas of ASPECT score be-
tween CT andDWI. For the presence or absence of RD, interobserver
agreement was evaluated with  agreement index.
Results
Demographic Data of Patients with Reversed Discrepancy
RD was found in 9 (12.9%) of 70 patients and located at basal
ganglia in 8 (88.8%) of 9 patients with RD. The  value for the
presence of RD was 0.97. In all patients with RD, DWI hyper-
intense lesions were also present. Table 1 shows the demo-
graphic data of 9 patients (5 men and 4 women; mean age,
72  12 years). The mean time to CT and MR imaging was
2.5  1.3 and 4.1  1.4 hours, respectively, after symptom
onset, and mean time interval between initial CT and MR
imaging was 1.6  0.9 hours. A second follow-up CT or MR
imaging was performed in 8 patients within 8 days (mean,
5.5 2.4 days). No second follow-up imaging was performed
in 1 patient (patient 4). In 4 patients, additional follow-up CT
or MR images were obtained 3 to 11 months after the initial
CT.
Extent of Ischemic Lesion and Arterial Occlusion
In 6 (66%) of the 9 patients with RD, ASPECTS of early isch-
emic lesion showing hypoattenuation on CT were lower than
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those on DWI, and mean ASPECTS of 9 patients with RD was
significantly lower on CT than those assessed on DWI (4.6
2.5 and 6.0 2.1, respectively,P .023). CTAwas obtained in
8 of 9 patients with RD. CTA showed occlusion of M1 in only
3 patients and patent M1 segment in the other 4 of the 7 pa-
tients who had RD in basal ganglia. In 1 patient with RD in the
frontal cortex, there was no arterial occlusion at CTA.
In 5 (56%) patients with RD, initialMRA vascular territory
on the affected sidewas smaller than that ofCT ischemic lesion
(ie, mismatch). Follow-up MRA 1 day after the initial MRA
demonstrated recanalization of arterial occlusions in 4 (50%)
of 8 patients with RDwho had arterial occlusions on the initial
MRA. In 29 patients without RD who underwent both initial
and follow-upMRA at day 1 and had arterial occlusions on the
initial MRA, recanalization was observed in 7 patients on
MRA at day 1. The recanalization rate of arterial occlusions at
day 1 was higher in the patients with RD than in those without
RD, but without significance (50% and 24%, respectively, P
.05).
Quantitative Measurement of Lesions Showing Reversed
Discrepancy
Table 2 demonstrates mean values of CT HU, DWI, and PWI
in lesions with RD on initial CT andMR imaging. The CTHU
and TTP of RD lesion was significant different from contralat-
eral control values (P .001, respectively), but ADCandother
MR imaging parameters of RD lesions were not different from
control values. The mean CT HU of RD lesion was not signif-
icantly different from those of DWI lesion 1 (P  .05), but it
was lower than that of DWI lesion 2 (P  .001). The mean
ADC, ADC ratio, and DW signal intensity ratios of RD lesions
were significantly different from those of DWI lesion 1 or 2
Fig 1. Patient 7. A, ROIs for parenchymal hypoattenuation and DWI hyperintensity were placed manually on unenhanced CT and DWI (TR, 10,000 ms; TE, 71.7 ms). The 2 ROIs for CT lesion
and DWI hyperintensity provide an ROI for the lesion with reversed discrepancy showing CT parenchymal hypoattenuation and no obvious DWI hyperintensity.
B, Initial unenhanced CT shows subtle hypoattenuation of lentiform nucleus, caudate, and insula in the left MCA territory (white arrows). A hyperattenuated artery sign of the left inferior
M2 branch (black arrow) is also seen. Maximum intensity projection CT angiography (CTA) shows occlusion of the left inferior M2 (arrow). DWI shows hyperintense lesions in the left
temporal lobe and posterior insula, but DWI hyperintensity seems very subtle and not obvious in basal ganglia and is not seen in most areas of insula. ADC map shows cytotoxic edema
in the left temporal lobe. Perfusion maps show an increased TTP delay and decreased rCBF only in the left temporal lobe, and no obvious perfusion abnormality is seen in the left basal
ganglia. Initial MRA shows occlusion of the left inferior M2 (arrow).
C, Follow-up MR images at day 1 show delayed DWI hyperintensity and decreased ADC in the left basal ganglia (arrow). Perfusion maps and MRA demonstrate reperfusion in the left
MCA territory and recanalization of the left M2 occlusion.
D, Follow-up CT and fluid-attenuated inversion recovery (FLAIR) images (TR, 10,000 ms; TE 133 ms; TI, 2200 ms) 7 days later show infarction in the RD lesion of basal ganglia and insula,
and DWI shows increased extent of DWI hyperintense lesion in the left basal ganglia. FLAIR and T2-weighted MR images (TR, 3683 ms; TE, 104 ms) obtained 9 months after the initial
CT show atrophy of the left basal ganglia and insula. T1 hyperintensity is seen in the left striatum at long-term follow-up. In this patient, there was a spontaneous rapid improvement
of aphasia and motor weakness within 1 hour after symptom onset.
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(P .001). ThemeanTTP and rCBF values of RD lesionswere
less delayed and higher than those of DWI lesion 1 or 2 (P
0.001, respectively). The mean rCBV value between RD lesion
andDWI lesion 1 or 2was not significantly different (P .05).
Table 2 shows changes inmeanADC,DWI signal intensity,
and T2 signal intensity values observed at the day-1 follow-up.
For RD or DWI lesions, mean ADC values were significantly
lower at follow-up than those at the initial DWI (P  .001),
and DWI and T2 signal intensities were higher than those at
the initial DWI (P .001). T2 signal intensities of RD lesions
were significantly lower than those of DWI lesion (P 0.001)
at the day-1 follow-up. The mean ADC value and DWI signal
intensity of RD lesions were significantly different from those
of DWI lesion (P .037 and P .001, respectively) at follow-
up. The day 1 follow-up DWI demonstrated delayed hyperin-
tensity of RD lesions in 8 (88.8%) of the 9 patients. In these 8
patients (except for 1 patient without a second follow-up im-
age), all RD lesions progressed to overt infarctions at second
follow-up. In 1 patient who had no delayed DWI hyperinten-
sity at RD lesion at day 1, RD lesion progressed to infarction at
the second follow-up. RD lesions converted to atrophy (n 2)
(Fig 1) or pan-necrosis (n  2) (Fig 2) in 4 patients who un-
derwent long-term follow-up CT or MR. The total area of CT
hypoattenuation lesions and area of RD lesionswas 500.25 and
128.47 cm2, respectively. The area of RD lesion was present in
25.7%of total area ofCT ischemic lesion in 9 patientswithRD.
Clinical Data Analysis
No significant difference was observed in the baseline NIHSS
scores (15.4  4.5 and 13.6  5.4), 24-hour NIHSS scores
Table 1: Clinical data of 9 patients with reversed discrepancy (RD)
Patient No./
Age (y)/Sex
Time to
CT (h)
Time to
MRA (h)
Arterior Occlusion
on Initial MRA
ASPECTS
Location of
RD
MR Findings at Day 1 Follow-up NIHSS
mRS at
Day 90CT DWI
Recanalization
on MRA
Delayed DWI
Hyperintensity
of RD lesion Initial Day 1
1/F/75 2.1 4.3 ICA 3 5 Left BG Absent Present 21 22 4
2/M/86 4.0 5.8 ICA 3 5 Right BG Absent Present 14 15 4
3/M/64 5.3 5.8 ICA 8 8 Left BG Absent Present 6 6 1
4/M/76 1.7 4.3 M1 4 3 Right BG Present Present 15 17 6
5/F/84 0.9 2.3 M1 1 5 Right BG Absent Absent 12 11 4
6/F/80 1.8 2.5 M2 7 9 Right BG Present Present 8 13 5
7/F/60 2.3 3.3 M2 7 7 Left BG Present Present 9 9 2
8/M/74 2.5 5.3 MCA distal branch, A2 6 8 Left insula,
frontal lobe
Present Present 18 16 3
9/M/50 2.2 4.0 * 2 4 Right BG No occlusion Present 13 8 2
Note:—CT indicates computed tomography; MRA, magnetic resonance angiography; DWI, diffusion-weighted MR imaging; ASPECTS, Alberta Stroke Program early CT score; mRS, modified
Rankin Scale; ICA, internal carotid artery; MCA, middle cerebral artery; BG, basal ganglia.
* Site of arterial occlusion was not accurately determined due to poor image quality of MRA.
Fig 2. Patient 8. A, Initial unenhanced CT shows parenchymal hypoattenuation and loss of gray-white matter distinction in the left
frontal lobe of ACA and MCA territory (arrows). Echo-planar spin-echo T2-weighted image (EPI T2, DWI of b value of 0, TR, 6500
ms; TE, 96.8 ms) shows no hyperintensity in the left frontal lobe. DWI (6500/96.8) and ADC map show hyperintensity and reduced
ADC only in the medial frontal cortex and precentral gyrus that are only a part of hypoattenuated ischemic lesion depicted on CT.
Perfusion maps show a TTP delay in the DWI lesion but no significant perfusion abnormality in the left frontal lobe lesion with
reversed discrepancy on CT and DWI (arrowheads). MRA shows decreased signal intensity of the left distal MCA branches (arrow)
and there was occlusion of the left A2 on MRA (not shown).
B, Follow-up MR images at day 1 show delayed DWI hyperintensity and ADC decrease in the left frontal lobe lesion with reversed
discrepancy (arrows) and more severe cytotoxic edema in the medial frontal cortex and precentral gyrus of the left frontal lobe.
Follow-up MRA shows recanalization of distal MCA branches but persistent perfusion abnormality in the ischemic lesion found on the initial DWI.
C, Follow-up CT image obtained 7 days after the initial CT demonstrates ischemic edema with heterogeneous hypoattenuation in the left frontal lobe. CT image obtained 11 months after
the initial CT shows overt infarction with necrosis in the lesion with reversed discrepancy.
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(13.7 5.4 and 10.1 6.2), or the chronicmRS (3.4 1.6 and
2.8  1.7) between those with and without RD on initial CT
and DWI (P .05). Spontaneous rapid clinical improvement
was found in 3 (30%) patients with RD and 2 (3%) of patients
without RD (P .013). No significant differencewas observed
in terms of duration from symptom onset to CT and MR im-
aging (2.5  1.3 versus 2.4  1.2 and 4.1  1.4 versus 3.8 
1.3, P .05) or in terms of the time interval between CT and
MR imaging (1.6 0.9 and 1.4 0.8, P .05). No difference
in the incidence of RD was found according to the time be-
tween onset andMR imaging, ie, 3 hours (13.0%, 3 of 23) and
3 to 6 hours after symptomonset (12.8%, 6 of 47) (P .05). In
1 of 9 patients with RD, hemorrhagic transformation was ob-
served in an RD lesion on T2* gradient-echo images at day-1
follow-up.
Discussion
Our study demonstrates that the early CT sign of parenchymal
hypoattenuation may be undetectable on DWI in patients
with acute cerebral ischemia. In 12.9% of patients with acute
stroke who did not undergo thrombolytic therapy, portions of
acutely ischemic brain tissue showed hypoattenuation on CT
but appeared normal on DWI images obtained immediately
afterward.
CT attenuation is linearly proportional to tissue water con-
tent,21 and an early CT sign of parenchymal hypoattenuation
develops under the severe CBF decrease because early isch-
emic edema accompanying uptake of tissue water develops
under CBF less than 10–15 mL/g/min.22 Meanwhile, the CBF
threshold for an ADC decrease is higher than that of CT, and
an ADC decrease occurs before CBF declines at the critical
threshold for energy failure.23,24 The presence of RD between
CT and DWI contradicts the general concept of higher sensi-
tivity of DWI for early ischemic tissue and the natures of the
correlations between CT attenuation and ADC or CBF.25,26
What, then, is the pathophysiology of RD? The results of
the present study suggest that RDmay be related to early spon-
taneous reperfusion, which is supported by the mismatch be-
tween the site of arterial occlusion and vascular territory for an
RD lesion, verymildly reduced to normalCBF in anRD lesion,
and higher incidence of rapid clinical improvement.However,
it is unclear why a hypoattenuated RD lesion has a normal
ADC.The normalADCofRD lesionmight be explained by the
transient normalization of ADC because of reperfusion, as has
been reported in previous studies.14,27-29 Pseudonormaliza-
tion of ADChas been shownwith previous animal and human
studies after early reperfusion.13,27-29 A number of theories
attempt to explain this phenomenon, but the exact cause is
unknown. As for the explanation of early ADC renormaliza-
tion, transient recovery from histologic cellular change by
early ischemia or water influx by reperfusion seems less likely
because ADC renormalization is not associated with a reversal
of astrocytic swelling or neuronal shrinkage, and more severe
ischemic tissue resulting in blood-brain barrier breakdown
has no ADC reversibility according to animal studies.27,28 The
finding of RD might give us a message similar to that of an
animal study,28 which showed a discrepancy between histo-
logic finding of persistent cytotoxic edema and reperfusion-
induced ADC renormalization. A theory of transient recovery
of energy metabolism suggested for explaining transient ADC
normalization29 might be also a possible explanation for RD
that CT hypoattenuation as a result of continuation of isch-
emic edemamay coexist with transient normalization of ADC
after early reperfusion. Nevertheless, it remains to be deter-
mined whether transient energy metabolism recovery can oc-
cur in ischemic tissue showing hypoattenuation on CT.
Although ADC decrease of ischemic tissue is related to cy-
totoxic edema and energy failure,27,30 the exact mechanism of
ADC decrease remains unclear.27,31 However, the finding of
RD evidently indicates that a decrease of CT attenuation has a
pathophysiology different from that of an ADC decrease in
acute cerebral ischemia The mechanism of CT hypoattenua-
tion in early ischemic tissue may be complex. It may be due to
a combination of increase in tissue water and low CBV.32
However, our data do not support the concept that lowCBV is
a direct major cause of CT signs of parenchymal hypoattenu-
ation because our data showed lack of CBV decrease in RD
lesion and presence of CT hypoattenuation without a con-
comitant arterial occlusion in some cases.
Although patients with RD showed higher incidence of
rapid clinical improvement, there was no significant associa-
tion with a better clinical outcome or significantly higher in-
cidence of spontaneous arterial recanalization than those
without RD. Further study is required to determine whether
early reperfusion may reduce the degree of tissue damage or
Table 2: Mean values of computed tomographic (CT) attenuation, apparent diffusion coefficient (ADC), diffusion-weighted MR imaging (DWI)*
Initial CT and MRI Follow-up MRI at day 1
RD Lesion
(ROIRD)
DWI
Lesion 1
(ROIDWII)
DWI
Lesion 2
(ROIDW12)
RD Lesion
(ROIRD)
Whole DWI
Lesion (ROIDW)
HU 2.33 0.74 2.90 1.34 0.18 0.28 — —
ADC (106 mm2/s) 830 91 658 108 665 112 677 163 614 184
ADC ratio 0.97 0.07 0.74 0.09 0.76 0.10 0.76 0.14 0.68 0.15
DWSI ratio 1.08 0.11 1.41 0.17 1.40 0.17 1.39 0.32 1.97 0.41
T2SI ratio 1.10 0.08 1.11 0.11 1.10 0.11 1.19 0.18 1.45 0.20
TTP delay (second) 2.56 1.66 9.09 5.37 9.01 5.39 0.06 1.81 5.63 5.02
Relative CBV 1.05 0.24 0.98 0.35 0.09 0.35 1.16 0.37 0.79 0.31
Relative CBF 0.87 0.20 0.59 0.31 0.59 0.31 1.31 0.41 0.75 0.37
Note:—Values are expressed as mean  SD. ROI indicates region of interest; HU indicates the difference between the Hounsfield unit of the lesion and the control; relative cerebral
blood volume (CBV) or cerebral blood flow (CBF) indicates the ratio of lesion value to that of contralateral hemisphere; DWSI, signal intensity on diffusion-weighted MR image; T2SI, signal
intensity on T2-weighted image.
* Perfusion weighted MR imaging (PWI) data of 1 patient was not included for the quantitative analysis of PWI values due to poor enhancement of the initial PWI.
1994 Kim  AJNR 27  Oct 2006  www.ajnr.org
functional injury in ischemic tissue showing CT
hypoattenuation.
Our study demonstrates that severe ischemic tissue show-
ing CT hypoattenuation could be missed in patients with un-
treated hyperacute ischemic stroke even within 3 hours of on-
set. Although DWI is usually more accurate, reliable, and
sensitive for early ischemic tissue than CT, it may be less sen-
sitive for depicting severe ischemic tissue than CT in some
patients if spontaneous early reperfusion occured within the
severe ischemic tissue. If one obtains only MR imaging in
acute stroke patients, ischemic lesions that are not visualized
on DWI but are destined to infarct may be present. Therefore,
although the utility of DWI for decision-making for thrombo-
lytic therapy is probably widely accepted, it should be recog-
nized that the evaluation of the extent of severe ischemic tissue
can be inaccurate by DWI, and caution should be exercised
when determining eligibility for thrombolytic therapy based
on the extent of ischemic tissue on DWI.
In conclusion, a finding of RD was uncommonly found in
untreated patients with acute MCA infarction and its patho-
physiologymay be related to pseudonormalization of ADC by
spontaneous early reperfusion in severe ischemic tissue. Se-
vere ischemic tissue showing an early CT sign of parenchymal
hypoattenuation may be undetectable on DWI and DWI may
underestimate its extent in patients with untreated acuteMCA
infarction.
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